GlassScriptPhysician profile
Scott Rudkin
NPI 1629456108
$3,147.79
in general payments reported to CMS, 2019-2025
8 companies · $505 in 2025
The $505 reported for 2025 was more than what a typical Neuroradiology provider received nationally (typical 2025 total: $278).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $138 · 2020: $98.97 · 2021: $162 · 2022: $574 · 2023: $803 · 2024: $868 · 2025: $505.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,175.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,175.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Penumbra, INC. | $1,038.70 | 2021-2025 | Penumbra System, Red 72, Penumbra Coil 400 |
| Medtronic, INC. | $930.45 | 2021-2025 | Pipeline, Axium Primetm, Solitaire X |
| Stryker Corporation | $557.99 | 2019-2024 | Spinejack, Trevo, Target |
| Inari Medical, INC. | $200.21 | 2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Depuy Synthes Sales INC. | $159.36 | 2023 | Cerepak Uniform |
| Route 92 Medical, INC. | $114.99 | 2025 | |
| Kaneka Medical America LLC | $95.87 | 2024 | |
| Cardiva Medical, INC. | $50.22 | 2023 | Cardiva Vascade 5f Vcs |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Rudkin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.